T. Nakabayashi

Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer.

N. Saijo, Y. Nishiwaki, Y. Kawakami, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics of granisetron in adults and children with malignant diseases.

H. Saitoh, M. Takada, T. Nakabayashi, 2001, Biological & pharmaceutical bulletin.

[A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].

M. Fukuoka, T. Kuriyama, H. Niitani, 1991, Gan to kagaku ryoho. Cancer & chemotherapy.

Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma

Hiroshi Suzuki, H. Kanno, T. Nakabayashi, 2021, The oncologist.

A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer.

Y. Kawakami, H. Miyamoto, H. Isobe, 1992, Oncology.

A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC).

T. Nukiwa, Y. Saijo, Y. Yamane, 2001, Lung cancer.

Limited sampling model for the area under the concentration versus time curve of irinotecan and its application to a multicentric phase II trial.

N. Saijo, Y. Nishiwaki, Y. Kawakami, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.